Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Equity Ratio (2020 - 2025)

Mirum Pharmaceuticals (MIRM) has 6 years of Equity Ratio data on record, last reported at 0.37 in Q4 2025.

  • For Q4 2025, Equity Ratio rose 10.99% year-over-year to 0.37; the TTM value through Dec 2025 reached 0.37, up 10.99%, while the annual FY2025 figure was 0.37, 10.99% up from the prior year.
  • Equity Ratio reached 0.37 in Q4 2025 per MIRM's latest filing, roughly flat from 0.37 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.6 in Q1 2021 and bottomed at 0.18 in Q2 2023.
  • Average Equity Ratio over 5 years is 0.37, with a median of 0.37 recorded in 2025.
  • Peak YoY movement for Equity Ratio: crashed 71.71% in 2021, then surged 95.56% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.41 in 2021, then dropped by 1.35% to 0.4 in 2022, then fell by 4.45% to 0.38 in 2023, then dropped by 12.53% to 0.34 in 2024, then increased by 10.99% to 0.37 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.37 in Q4 2025, 0.37 in Q3 2025, and 0.35 in Q2 2025.